James Lind Care is a patient recruitment company that specialises in servicing global pharmaceutical companies with patient recruitment services for clinical trials and patient engagement activities in Europe. We provide a high-quality patient recruitment service that accelerates enrolment and ensures sponsors’ recruitment targets for their clinical trials in Europe are met.
By understanding and caring for the needs of both patients and pharmaceutical companies, we have built a strong reputation for high-quality patient recruitment to clinical research and patient engagement activities.
With a proven track record of helping global pharmaceutical companies to meet patient recruitment deadlines, reach enrolment targets, and avoid delays by solving their patient recruitment issues, we have become the preferred patient recruitment partner for global pharmaceutical companies for clinical trials and patient engagement activities.
At James Lind Care, we care about patient recruitment, so let’s take care of the patient recruitment for your clinical trial!
Avoiding risk of clinical trial delays due to efficient patient recruitment service
Of all delayed clinical trials worldwide, 80% are delayed due to patient recruitment problems. This can turn out to be a costly affair, with one day’s delay estimated to cost $500,000.
With James Lind Care’s proven track record of accelerating enrolment and meeting recruitment targets in Europe, we are happy to help you avoid the risk of your clinical trial being delayed due to patient recruitment issues in European countries. We are the leading patient recruitment vendor for pharmaceutical companies when it comes to enrolling clinical trial participants in the western European countries.
By choosing James Lind Care’s patient recruitment service, we will ensure you meet your recruitment targets in Europe and avoid the risk of being delayed due to patient recruitment issues.
Over 250,000 patient community members in Europe ready to participate in clinical trials
James Lind Care does patient recruitment for clinical trials differently from other patient recruitment companies, and that’s why we are able to deliver a higher quality of service that meets the needs of pharmaceutical companies. We believe that successful enrolment is achieved through a genuine understanding and care of the patients’ interests.
Our ability to deliver a fast, efficient and patient-centric patient recruitment service is based on our expertise in engaging and guiding patients into participation in clinical trials via our digital patient communities, with more than 250,000 members across Europe. We have a digital patient community in each of the European countries we operate in, and all of our members are patients living with chronic diseases and have signed up to be invited to participate in clinical trials.
Via our patient communities, James Lind Care can offer patients participation in relevant clinical trials and create a link between them and clinical research. This allows us to provide pharmaceutical companies with unique access to patients’ perspectives.
We provide our members with numerous member services, such as newsletters and articles on clinical trials and research. We also provide our members with access to participate in surveys about patients’ needs in clinical trials, as well as a notification service where each member is informed about new and relevant clinical trials in their region.
Team of highly experienced Research Nurses guarantees enrolment of excellence
James Lind Care’s patient recruitment service is highly appreciated by clinical research sites all over Europe. This is underscored by sites reporting that our service is a vital support to reaching their recruitment targets.
One of the main reasons for the high level of satisfaction for our patient recruitment services among clinical trial sites is that we have a team of local and experienced research nurses in each European country. Our team of experienced and dedicated research nurses are trained in the protocol and exchange insights with the clinical trial site’s personnel prior to starting the patient recruitment service. This allows us to carry out the best possible site referral of clinical trial participants.
James Lind Care’s Research Nurses provide attentive guidance and qualification for each patient we refer to the clinical trial sites. This enables us to refer highly eligible and well-prepared patients for enrolment into the clinical trial.
Finding the right patients by listening to patients’ perspectives
Before engaging in any patient enrolment activity, James Lind Care performs an analysis of the clinical trial as seen from the patients’ perspectives. This is to ensure that our patient recruitment activities meet the patients’ needs for communication when they are being informed and invited about participation in the clinical trial.
By understanding the patients’ perspective, we can refer well-informed, thoroughly qualified and motivated patients to the trial sites. This results in low screen failures and low drop-out rates.
We start our patient outreach activities by notifying the relevant patients among our community members. Feedback from our members provides valuable insights into how the enrolment process will perform in every step until randomisation.
James Lind Care’s patient communities also partner with patient organisations, Facebook groups and other patient bodies for all diseases. This provides us with an extraordinary large outreach to patients.
Social media campaigns play an important role in making interested patients aware of relevant clinical trials in their region. James Lind Care’s SoMe specialists develop and manage these campaigns on Facebook with the highest yield.
Improve your patient engagement activities through our patient recruitment
At James Lind Care, we link patients with pharmaceutical companies in clinical research. Via our patient communities, we can provide pharmaceutical companies with unique access to patients’ perspectives and very specific patient groups in Europe.
We have experience in working with patients’ review on patient-facing material, surveys presenting the patients’ perspective on a specific topic or knowledge about disease area. We also deliver patients’ insights which could be around topics such as decentralised trials, artificial intelligence, or the design of patient-centric clinical trials.
Our vision is that one day, it will be an obvious choice for all patients to engage in clinical trials.